Abyssinia Biologics
Abyssinia is altering the world&s;s understanding of Alzheimer&s;s Disease from diagnostic assays with the potential for early diagnosis.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Abyssinia Biologics Information
Geographic Data
Address:
City: Portsmouth
State: New Hampshire
Zip:
Country: United States
Financial Info
Stage:
grant
Raised Last:
$12k
Raised Total:$17k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Abyssinia is altering the world&s;s understanding of Alzheimer&s;s Disease from diagnostic assays with the potential for early diagnosis to treatment approaches addressing novel disease causes. Abyssinia&s;s lead candidate ABY-71A1 is a IgG1 mAb with a high specificity for toxic soluble amyloid oligomers, which is backed up by our companion diagnostic assay for soluble amyloid in plasma &a; CSF. Abyssinia was founded in 2017.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Grant | 1 | $11.5k |
Maine Technology Institute Maine Technology Institute |
4/2018 | Seed Round | 1 | $5k |
Maine Technology Institute Maine Technology Institute |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
